Clinical Trial

Tirzepatide for the Treatment of Cannabis Use Disorder

Name: Tirzepatide for the Treatment of Cannabis Use Disorder — clinical trial record (NCT07265752)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a pilot randomized cross-over trial to examine the effects of tirzepatide on cue-reactivity among individuals with cannabis use disorder.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-25.

Trial Details

NCT Number	NCT07265752
Lead Sponsor	Brigham and Women's Hospital
Conditions	Cannabis Use Disorder
Enrollment	6 participants
Start Date	2026-07-01
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-18